Clinical trial shows safety and immunogenicity of temperature-stable experimental TB vaccine
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system.